News|Articles|May 13, 2024
Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends
Author(s)Pfizer CentreOne
Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
Raman Spectroscopy—A Game-Changer in the Fight Against Counterfeit Drugs
5
